My SciELO
Services on Demand
Article
Indicators
- Cited by SciELO
Related links
- Similars in SciELO
Share
Revista Cubana de Hematología, Inmunología y Hemoterapia
On-line version ISSN 1561-2996
Abstract
TELLO VERA, Stalin. Treatment of idiopathic pulmonary fibrosis with autologous adult bone marrow stem cells. Rev Cubana Hematol Inmunol Hemoter [online]. 2022, vol.38, n.3 Epub Sep 01, 2022. ISSN 1561-2996.
Introduction:
Idiopathic pulmonary fibrosis represents a degenerative disease with a dire prognosis, whose therapeutic options are very limited, so it is necessary to evaluate alternatives available to the population.
Objective:
To evaluate treatment with autologous adult bone marrow (BM) stem cells in a 68-year-old patient with a radiological diagnosis of pulmonary fibrosis and dyspnea at rest.
Case presentation:
The patient attended the consultation with dyspnea at rest, and digital saturation of 74%, which after her first intravenous treatment with adult bone marrow stem cells, achieved significant improvement, with saturations ranging between 85 and 90% at 4 months after the first therapy. Eight months after the first session, she received a second dose, with which she increased the saturation to values between 94 and 97%, three weeks after the latter.
Conclusion:
Conclusion: Treatment with autologous adult bone marrow stem cells could improve the signs and symptoms of patients with idiopathic pulmonary fibrosis.
Keywords : idiopathic pulmonary fibrosis; adult stem cells; bone marrow.